# US Vitamin K2 Market > US Vitamin K2 Market Research Report: By Product Type (MK-7, MK-4, Combination Drugs), By Source (Natural, Synthetic), By Form (Capsules & Tablets, Powder, Oil) and By Application (Nutraceutical, Food, Pharmaceutical) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 4.46% - **2024:** $ 26 Billion - **2025:** $ 27.16 Billion - **2035:** $ 42 Billion - **Key Players:** NattoPharma (NO), Ginkgo BioWorks (US), Kappa Bioscience (NO), DSM Nutritional Products (CH), MenaQ7 (NL), FrieslandCampina (NL), Nutraceutical Corporation (US), Swanson Health Products (US) **Report ID:** MRFR/HC/12012-HCR · **Pages:** 100 · **Author:** Rahul Gotadki & Garvit Vyas · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/us-vitamin-k2-market-13537 --- ## Market Summary ## **US Vitamin K2 Market Overview** As per MRFR analysis, the US Vitamin K2 Market Size was estimated at 26.61 (USD Billion) in 2023. The US Vitamin K2 Market Industry is expected to grow from 30(USD Billion) in 2024 to 2.5 (USD Billion) by 2035. The US Vitamin K2 Market CAGR (growth rate) is expected to be around -20.22% during the forecast period (2025 - 2035).A ### **Key US Vitamin K2 Market Trends Highlighted** The US Vitamin K2 Market has been experiencing notable trends driven by increased consumer awareness of health and nutrition. With rising concerns about bone health and cardiovascular diseases, individuals are turning towards supplements that can promote wellbeing, making Vitamin K2 increasingly popular. The trend towards preventive healthcare is significantly influencing the market, as consumers seek to enhance their diets with nutrients that support skeletal and cardiovascular systems. Additionally, the aging population in the US has led to a greater demand for supplements that help maintain bone density and cardiovascular health, subsequently amplifying the relevance of [Vitamin K2](../../../reports/vitamin-k2-market-7495). Opportunities to be explored in the US Vitamin K2 Market include a growing inclination for natural and organic products. Consumers are now leaning towards dietary supplements that are derived from natural sources rather than synthetic alternatives. This shift creates space for brands to develop innovative Vitamin K2 products sourced from fermentation processes or plant-based origins. Furthermore, the rise of e-commerce in recent years has provided manufacturers and retailers with direct access to consumers, facilitating increased product visibility and sales. Recent times have witnessed an upsurge in research linking Vitamin K2 to various health benefits, such as improved arterial health and enhanced calcium metabolism. These findings are redirecting attention towards the role of this vitamin, encouraging health practitioners to recommend it more frequently. Overall, with ongoing research and a clearer understanding of the benefits of Vitamin K2, the US market is poised to grow as consumers increasingly incorporate it into their daily supplement routines. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **US Vitamin K2 Market Drivers** ### **Increasing Awareness of Bone Health** In the United States, the growing awareness of the importance of bone health among consumers is a crucial driver for the US Vitamin K2 Market Industry. Research from the National Institutes of Health indicated that approximately 54 million U.S. adults are at risk of osteoporosis and low bone mass. This figure represents nearly 50% of older adults in the US, highlighting an urgent need for nutritional support in bone health. Vitamin K2 plays a significant role in calcium metabolism and is essential in maintaining bone density. Organizations like the National Osteoporosis Foundation emphasize the importance of adequate vitamin intake, which can encourage consumers to adopt supplements. As more people seek proactive solutions to prevent bone-related diseases, the demand for Vitamin K2 supplements is expected to soar, thereby positively impacting the market growth in the US. ### **Growing Aging Population** The demographic shift toward an older population in the United States serves as a major driver for the US Vitamin K2 Market Industry. According to the U.S. Census Bureau, by 2030, one in five Americans will be age 65 or older, which translates to roughly 78 million people. This aging demographic is more susceptible to various health issues, including osteoporosis and cardiovascular diseases, both of which can benefit from Vitamin K2 supplementation. The American Heart Association reports an increase in cardiovascular diseases among older adults, which can be managed through adequate Vitamin K2 intake. As healthcare providers and consumers become increasingly aware of these critical health factors, the rise in Vitamin K2 supplement demand is likely to reflect this demographic transition. ### **Rising Interest in Nutraceuticals** There is an escalating trend toward nutraceuticals in health-conscious consumers in the United States, driving the US Vitamin K2 Market Industry upward. The International Trade Administration noted that the nutraceutical market in the US is expected to reach around $301 billion by 2025, highlighting a growing preference for dietary supplements, including vitamins and minerals. As more consumers opt for natural and holistic wellness solutions, products containing Vitamin K2 are increasingly favored. Companies such as DSM Nutritional Products focus on the development and marketing of Vitamin K2 as a vital component of innovative nutraceuticals, propelling customer interest and subsequently boosting market growth. This rising popularity and shift towards preventative health measures underline the increasing consumption of Vitamin K2. ## **US Vitamin K2 Market Segment Insights** ### **Vitamin K2 Market Product Type Insights** The US Vitamin K2 Market is characterized by its diverse Product Type segmentation, which plays a crucial role in catering to various consumer needs and health benefits. Among the different types of Vitamin K2, MK-7 stands out due to its longer half-life and superior bioavailability when compared to other forms. This makes it increasingly popular in dietary supplements, contributing significantly to consumer health outcomes related to heart and bone health. MK-4, on the other hand, is recognized for its efficacy in addressing specific health issues, including osteoporosis and arterial health, and is particularly prevalent in certain dietary supplements targeting these conditions. Combination Drugs, which synergize the effects of Vitamin K2 with other essential nutrients, provide a comprehensive approach to health management, appealing to consumers looking for holistic wellness solutions. The interplay among these product types reflects changing consumer preferences towards preventive healthcare and wellness, driven by an increasing awareness of the importance of Vitamin K2 in supporting overall health. This segment's dynamics underscore the importance of ongoing market growth, influenced by various factors such as lifestyle changes and an aging population seeking effective nutritional supplements to enhance their quality of life. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Vitamin K2 Market Source Insights** The US Vitamin K2 Market, specifically regarding its Source segment, encompasses both Natural and Synthetic categories, which play crucial roles in the industry. Natural Vitamin K2, often derived from sources like fermented foods and specific plant extracts, is gaining popularity due to the increasing consumer preference for organic and health-oriented products. This trend aligns with the growing awareness of the benefits of Vitamin K2 for bone health and cardiovascular wellness. On the other hand, Synthetic Vitamin K2 is significant for its accessibility and cost-effectiveness, appealing to manufacturers looking to diversify product offerings. The differentiation between these segments highlights consumer choices related to health and sustainability, thus driving market growth. The US is observing a shift towards fortified foods and dietary supplements, which further enhances the relevance of both Natural and Synthetic offerings in the Vitamin K2 Market. As regulatory frameworks evolve, these sources will become pivotal in responding to health claims, scientific research, and consumer demand in the ever-competitive landscape of the US Vitamin K2 Market industry. ### **Vitamin K2 Market Form Insights** The Form segment of the US Vitamin K2 Market plays a pivotal role in defining the market landscape, particularly with the increasing consumer demand for supplements that support bone and cardiovascular health. Within this segment, capsules and tablets are among the most popular formats, largely due to their convenience and ease of use, appealing to health-conscious individuals seeking dietary supplements. Powders also represent a growing preference, offering versatility for inclusion in various formulations, particularly among fitness enthusiasts and those interested in wellness trends. Oil-based forms, while less dominant, cater to a niche market that values liquid nutrients for better absorption. This diversity in the Form segment allows for targeted marketing strategies that align with consumer preferences and lifestyle choices in the US, fostering market growth. Ultimately, the segmentation provides manufacturers with opportunities to innovate and adapt to the dynamic requirements of the health supplement industry, reinforcing the importance of each format in addressing specific consumer needs in the US Vitamin K2 Market. ### **Vitamin K2 Market Application Insights** The Application segment of the US Vitamin K2 Market showcases significant potential across various fields, primarily focusing on Nutraceutical, Food, and Pharmaceutical applications. The Nutraceutical sector is crucial as it taps into the growing trend of preventative health, providing dietary supplements that enhance bone health and cardiovascular functions, thereby driving market growth. In the Food industry, Vitamin K2's integration into functional foods reflects the increasing consumer demand for health-oriented food products, catering to a health-conscious market. The Pharmaceutical application plays a vital role as well, where Vitamin K2 is pivotal in the development of formulations aimed at treating specific conditions, highlighting its therapeutic benefits. Together, these applications contribute cumulatively to the US Vitamin K2 Market statistics, reflecting a diverse and robust segmentation that is adapting to health trends and consumer needs. The demand in these sectors is supported by changing lifestyles, the rise in preventive healthcare measures, and advancements in health-related research, reflecting a dynamic landscape that offers both opportunities and challenges for stakeholders involved. ## **US Vitamin K2 Market Key Players and Competitive Insights** The US Vitamin K2 market has been gaining attention due to the increasing consumer awareness around the health benefits associated with this nutrient, particularly in bone health and cardiovascular well-being. The competition within this market is characterized by a diverse range of players offering various formulations of Vitamin K2, targeting different consumer segments, including dietary supplements and functional foods. As the trend towards preventive healthcare and natural supplementation continues to rise, market participants are leveraging innovative approaches to cater to consumer demands. Brands are focusing on product differentiation, quality assurance, and effective marketing strategies, which play a crucial role in sustaining their competitive edge in this evolving market landscape. The growth of e-commerce and online retailing has also intensified competition, enabling companies to reach broader audiences and diversify their distribution strategies. ### **Solgar** Solgar represents a strong force in the US Vitamin K2 market through its longstanding reputation for quality and efficacy in nutritional supplements. The brand enjoys consumer trust built over decades, positioning itself as a reliable choice in health and wellness. Solgar emphasizes the use of natural ingredients and scientifically-backed formulations, which appeal to health-conscious consumers seeking high-quality Vitamin K2 products. The brand’s strengths lie in its commitment to research, rigorous manufacturing standards, and extensive range of products designed to meet varying consumer preferences. Solgar has built a robust distribution network across both online platforms and brick-and-mortar stores, ensuring a strong market presence that allows easy access for consumers throughout the United States. ### **Ginkgo BioWorks** In the US Vitamin K2 market, Ginkgo BioWorks has established a recognized presence primarily through its innovative approach to biotechnology and sustainable solutions. The company focuses on producing high-quality, bioengineered products that meet the rising consumer demand for sustainable and effective health supplements. Ginkgo BioWorks leverages cutting-edge synthetic biology techniques to enhance the quality and bioavailability of Vitamin K2, making their offerings appealing to both health enthusiasts and environmentally conscious consumers. The company’s strengths include a strong emphasis on research and development, which enables it to continually enhance its product lines. Additionally, Ginkgo BioWorks has engaged in strategic collaborations and partnerships to expand its market reach and share knowledge in the field of nutritional supplements. These collaborations often lead to co-developing new formulations and entering new segments within the health and wellness market, further solidifying its position in the competitive landscape of the US Vitamin K2 market. ### **Key Companies in the US Vitamin K2 Market Include** ## **US Vitamin K2 Market Industry Developments** Recent developments in the US Vitamin K2 market have shown significant growth and attention, particularly among key players such as Solgar, Ginkgo BioWorks, NOW Foods, NattoPharma, and DSM Nutritional Products. The market has been expanding as awareness of the health benefits of Vitamin K2, particularly in supporting bone and cardiovascular health, rises among consumers. In terms of mergers and acquisitions, notable moves have included Kappa Bioscience expanding its portfolio in early 2023 by acquiring related product lines to enhance their K2 offerings, indicative of the market’s robust consolidation trend. Growth projections indicate that the market valuation for Vitamin K2 products is anticipated to rise sharply through the coming years, driven by increasing demand in dietary supplements and functional foods. A notable event in the last two years occurred in April 2022 when NutraIngredients-USA reported a spike in interest for plant-based Vitamin K2 sources, demonstrating evolving consumer preferences. Additionally, companies like MenaQ7 have been actively involved in clinical studies to substantiate the efficacy and safety of their Vitamin K2 products, enhancing credibility within the industry. This dynamic environment positions the US Vitamin K2 market for continued growth and innovation. ## **US Vitamin K2 Market Segmentation Insights** ### **Vitamin K2 Market Product Type Outlook** ### **Vitamin K2 Market Source Outlook** ### **Vitamin K2 Market Form Outlook** ### **Vitamin K2 Market Application Outlook** - Nutraceutical - Food - Pharmaceutical ## Market Drivers ### Growing Health Consciousness The increasing health consciousness among consumers in the US is a pivotal driver for the vitamin k2 market. As individuals become more aware of the importance of nutrition and its impact on overall health, the demand for dietary supplements, including vitamin k2, is likely to rise. This trend is reflected in the market data, which indicates that the vitamin k2 market is projected to grow at a CAGR of approximately 8% over the next five years. Consumers are actively seeking products that support bone and cardiovascular health, which vitamin k2 is known to promote. This heightened awareness is fostering a more informed consumer base that prioritizes health and wellness, thereby propelling the vitamin k2 market forward. ### Aging Population and Health Needs The aging population in the US is a critical driver for the Vitamin K2 market. As the demographic landscape shifts, there is a growing need for supplements that support bone health and cardiovascular function, areas where vitamin k2 has shown potential benefits. Data indicates that individuals aged 50 and above are increasingly turning to dietary supplements, with approximately 40% of this demographic reporting regular use of vitamin k2. This trend is likely to continue as the population ages, creating a sustained demand for vitamin k2 products. The vitamin k2 market is thus positioned to capitalize on this demographic shift, catering to the health needs of older adults seeking to maintain their quality of life. ### Innovations in Product Formulations Innovations in product formulations are significantly influencing the vitamin k2 market. Manufacturers are increasingly developing new and improved delivery forms, such as gummies, powders, and capsules, to cater to diverse consumer preferences. This diversification not only enhances the appeal of vitamin k2 products but also broadens their accessibility. Recent market analysis suggests that the introduction of innovative formulations has contributed to a surge in sales, with the market experiencing a notable increase in revenue, estimated at $150 million in the last fiscal year. As companies continue to invest in research and development, the vitamin k2 market is expected to benefit from enhanced product offerings that meet the evolving needs of consumers. ### Increased Focus on Preventive Healthcare The increased focus on preventive healthcare is driving growth in the Vitamin K2 market. As healthcare costs continue to rise, consumers are becoming more proactive about their health, seeking supplements that can help prevent chronic diseases. Vitamin k2, known for its role in bone and cardiovascular health, is gaining traction among health-conscious individuals. Recent surveys indicate that nearly 30% of consumers are actively seeking preventive supplements, with vitamin k2 being a key component of their health regimen. This trend aligns with a broader societal shift towards wellness and preventive care, suggesting that the vitamin k2 market will likely see sustained growth as more individuals prioritize preventive health measures. ### Rising Popularity of Natural Ingredients The rising popularity of natural ingredients in dietary supplements is shaping the Vitamin K2 market. Consumers are increasingly favoring products that are derived from natural sources, as they perceive these to be safer and more effective. This shift towards natural ingredients is evident in the growing demand for vitamin k2 sourced from fermented foods, such as natto. Market data suggests that products containing natural vitamin k2 are experiencing higher sales growth compared to synthetic alternatives. This trend indicates a broader movement towards clean label products, which is likely to enhance the appeal of vitamin k2 in the market. As consumers continue to prioritize natural health solutions, the vitamin k2 market stands to benefit from this evolving preference. ## Future Outlook The [Vitamin K2 Market](https://www.marketresearchfuture.com/reports/vitamin-k2-market-7495) is projected to grow at 4.46% CAGR from 2025 to 2035, driven by increasing health awareness and dietary supplement demand. **New opportunities:** - Development of targeted marketing campaigns for specific demographics Expansion into e-commerce platforms for direct consumer sales Partnerships with health professionals for product endorsements By 2035, the vitamin K2 market is expected to achieve robust growth and increased consumer adoption. ## Segment Insights ### By Product Type: MK-7 (Largest) vs. MK-4 & Combination Drugs (Fastest-Growing) In the US vitamin k2 market, MK-7 holds the largest share, primarily due to its widespread recognition and established benefits in promoting bone and cardiovascular health. On the other hand, MK-4 & combination drugs are gaining traction, appealing to consumers seeking targeted health solutions. The distribution of market share highlights the dominance of MK-7, while the emerging interest in MK-4 reflects a shift towards more specialized products in the market. Growth trends indicate a rising awareness of the health benefits associated with vitamin k2, particularly MK-7, which is being touted in various health circles. Factors driving the increase in MK-4 & combination drugs include an aging population seeking preventative health measures and increased research validating the efficacy of these products. This dual growth scenario emphasizes a diverse consumer base with varying health needs and preferences for vitamin k2 products. MK-7 (Dominant) vs. MK-4 & Combination Drugs (Emerging) MK-7 is recognized as the dominant product type in the vitamin k2 segment, celebrated for its long half-life and superior bioavailability, which enhances its efficacy in supporting bone density and cardiovascular health. Its popularity is bolstered by extensive marketing and research-backed claims. In contrast, MK-4 & combination drugs represent an emerging segment, appealing to consumers looking for specific health benefits and synergistic formulations. This combination approach, along with increasing clinical studies, has positioned MK-4 to cater to niche markets. The growth in this segment reflects a broader trend towards personalized nutrition and supplementation, responding to diverse health concerns among consumers. ### By Source: Natural (Largest) vs. Synthetic (Fastest-Growing) The US vitamin k2 market is segmented into natural and synthetic sources. Natural vitamin k2 is currently the largest segment, benefiting from a strong consumer preference for organic and naturally-derived products. This segment encompasses various forms derived from fermented foods and animal sources, catering to health-conscious consumers who prioritize quality and efficacy. On the other hand, the synthetic segment, while smaller in size, is rapidly gaining traction due to its cost-effectiveness and the increasing demand for supplement formulations that include precise dosages of vitamin K2. In terms of growth trends, the natural segment is experiencing steady demand driven by rising awareness of health and wellness, leading consumers to seek out high-quality supplements. Meanwhile, the synthetic market is positioning itself as the fastest-growing segment, fueled by innovations in production technology and surging demand for fortified foods and dietary supplements. This dynamic indicates a potential shift in consumer preferences, with synthetic options appealing to a broader audience seeking affordable yet effective vitamin K2 solutions. Source: Natural (Dominant) vs. Synthetic (Emerging) In the US vitamin k2 market, natural sources are recognized as the dominant player, largely due to their alignment with the clean-label trend that consumers are increasingly favoring. Natural vitamin k2 is typically derived from sources such as natto and fermented dairy products, appealing to an audience that prioritizes authenticity and health benefits. Conversely, synthetic vitamin k2 is emerging as a significant contender, appealing to manufacturers for its versatility and consistency in formulation. Its increasing incorporation into dietary supplements reflects growing consumer acceptance of synthetic alternatives, especially among those looking for convenience and affordability. As the market matures, both segments are poised for continued development, catering to diverse consumer preferences. ### By Form: Capsules & Tablets (Largest) vs. Powder (Fastest-Growing) In the US vitamin k2 market, the segment distribution shows that Capsules & Tablets dominate the forms available, capturing the largest market share. Their convenience and effectiveness appeal to consumers, making them the most preferred choice. On the other hand, the Powder form is gaining traction, especially among fitness enthusiasts and health-conscious individuals looking for more versatile options. This segment is witnessing increasing popularity due to its ease of incorporation into smoothies and other food products. Growth trends indicate that while Capsules & Tablets remain the go-to choice for many, the Powder segment is emerging as a fast-growing alternative. Factors such as rising health awareness, a shift towards preventive healthcare, and the increasing interest in holistic wellness are driving this trend. This shift demonstrates a broader acceptance of varied delivery forms in the health supplement sector. Capsules & Tablets: Dominant vs. Powder: Emerging The Capsules & Tablets segment remains dominant in the US vitamin k2 market, largely due to their established presence and consumer trust. They are perceived as traditional and reliable forms of supplementation, making them a staple for many users. The convenience of dosage and portability adds to their appeal, particularly for individuals with busy lifestyles. In contrast, the Powder form is considered an emerging choice, favored for its versatility and ability to cater to diverse consumer needs. Health-conscious individuals often prefer Powders for their potential to easily mix into foods or drinks, thus facilitating a more personalized approach to supplementation. This growing interest highlights a shift towards more adaptive consumption patterns among consumers. ### By Application: Nutraceutical (Largest) vs. Food & Pharmaceutical (Fastest-Growing) In the US vitamin k2 market, The Nutraceutical segment holds a dominant share, recognized for its widespread use in dietary supplements aimed at health-conscious consumers. This segment's appeal largely stems from the growing awareness of the health benefits of vitamin k2, contributing to its strong demand and leading market position. Meanwhile, the food and pharmaceutical segment, while smaller, is rapidly gaining traction as manufacturers aim to incorporate vitamin k2 into functional foods and medicinal products, thereby expanding its reach to a more diverse customer base. Growth trends in this segment indicate that the nutraceutical market will continue to thrive, driven by increasing health awareness and aging populations seeking preventive healthcare options. Conversely, the food and pharmaceutical segment is emerging swiftly, propelled by innovations in food fortification and a rise in research demonstrating the health benefits of vitamin k2, leading to increased product launches in this category. Nutraceutical: Dominant vs. Food & Pharmaceutical: Emerging The nutraceutical segment in the US vitamin k2 market is characterized by its robust consumer demand, primarily driven by individuals seeking preventive health solutions and dietary enhancement. This segment benefits from established distribution channels and a wide variety of available products, from capsules to fortified foods. On the other hand, the food and pharmaceutical segment is emerging with innovative applications in the production of functional foods and supplements. This segment is marked by growing investments in research and development, as well as partnerships with food manufacturers aiming to enhance product offerings with vitamin k2. As consumer trends shift towards health-focused eating and lifestyle choices, both segments are poised for growth, albeit at different paces. ## Competitive Benchmarking The vitamin K2 market exhibits a dynamic competitive landscape characterized by a blend of innovation, strategic partnerships, and a focus on sustainability. Key players such as NattoPharma (NO), Ginkgo BioWorks (US), and Kappa Bioscience (NO) are actively shaping the market through their distinct operational strategies. NattoPharma (NO) emphasizes research and development, particularly in clinical studies that validate the health benefits of vitamin K2, thereby enhancing its product credibility. Ginkgo BioWorks (US) leverages its synthetic biology expertise to optimize the production of vitamin K2, positioning itself as a leader in biotechnological advancements. Meanwhile, Kappa Bioscience (NO) focuses on expanding its global footprint through strategic partnerships, enhancing its distribution capabilities and market reach. Collectively, these strategies contribute to a competitive environment that is increasingly driven by innovation and scientific validation.In terms of business tactics, companies are localizing manufacturing and optimizing supply chains to enhance efficiency and responsiveness to market demands. The competitive structure of the vitamin K2 market appears moderately fragmented, with several players vying for market share. However, the influence of major companies is significant, as they set industry standards and drive trends that smaller firms often follow. This interplay between established players and emerging companies fosters a vibrant market environment, where innovation is paramount. In October NattoPharma (NO) announced a collaboration with a leading health food retailer to launch a new line of vitamin K2 supplements aimed at the growing health-conscious consumer segment. This strategic move is likely to enhance NattoPharma's visibility and accessibility in the market, potentially increasing its market share. The partnership underscores the importance of aligning product offerings with consumer trends, particularly in the wellness sector. In September Ginkgo BioWorks (US) unveiled a new production facility designed to scale up its vitamin K2 manufacturing capabilities. This facility is expected to utilize advanced biotechnological processes, which may significantly reduce production costs and improve product quality. Such advancements not only bolster Ginkgo's competitive position but also reflect a broader trend towards automation and efficiency in the industry. In August Kappa Bioscience (NO) secured a strategic partnership with a prominent European dietary supplement brand, aimed at co-developing innovative vitamin K2 formulations. This collaboration is indicative of Kappa's strategy to enhance its product portfolio and leverage the expertise of established brands to penetrate new markets. The partnership may facilitate the introduction of novel products that cater to evolving consumer preferences, thereby strengthening Kappa's market position. As of November current trends in the vitamin K2 market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence in production processes. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in driving innovation and expanding market reach. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on technological advancements, product innovation, and supply chain reliability. This shift suggests that companies that prioritize these areas will be better positioned to thrive in an increasingly competitive landscape. ## Recent News & Developments Recent developments in the US Vitamin K2 Market have shown significant growth and attention, particularly among key players such as Solgar, Ginkgo BioWorks, NOW Foods, NattoPharma, and DSM Nutritional Products. The market has been expanding as awareness of the health benefits of Vitamin K2, particularly in supporting bone and cardiovascular health, rises among consumers. In terms of mergers and acquisitions, notable moves have included Kappa Bioscience expanding its portfolio in early 2023 by acquiring related product lines to enhance their K2 offerings, indicative of the market’s robust consolidation trend. Growth projections indicate that the market valuation for Vitamin K2 products is anticipated to rise sharply through the coming years, driven by increasing demand in dietary supplements and functional foods. A notable event in the last two years occurred in April 2022 when NutraIngredients-USA reported a spike in interest for plant-based Vitamin K2 sources, demonstrating evolving consumer preferences. Additionally, companies like MenaQ7 have been actively involved in clinical studies to substantiate the efficacy and safety of their Vitamin K2 products, enhancing credibility within the industry. This dynamic environment positions the US Vitamin K2 Market for continued growth and innovation. ## Report Scope | MARKET SIZE 2024 | 26.0(USD Billion) | | --- | --- | | MARKET SIZE 2025 | 27.16(USD Billion) | | MARKET SIZE 2035 | 42.0(USD Billion) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 4.46% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Billion | | Key Companies Profiled | NattoPharma (NO), Ginkgo BioWorks (US), Kappa Bioscience (NO), DSM Nutritional Products (CH), MenaQ7 (NL), FrieslandCampina (NL), Nutraceutical Corporation (US), Swanson Health Products (US) | | Segments Covered | Product Type, Source, Form, Application | | Key Market Opportunities | Growing consumer awareness of health benefits drives demand for innovative vitamin K2 formulations. | | Key Market Dynamics | Rising consumer awareness drives demand for vitamin K2 supplements, influencing market growth and competitive strategies. | | Countries Covered | US | ## Frequently Asked Questions **Q: What was the overall market valuation of the US vitamin K2 market in 2024?** A: The overall market valuation of the US vitamin K2 market was $26.0 Billion in 2024. **Q: What is the projected market valuation for the US vitamin K2 market by 2035?** A: The projected market valuation for the US vitamin K2 market is $42.0 Billion by 2035. **Q: What is the expected CAGR for the US vitamin K2 market during the forecast period 2025 - 2035?** A: The expected CAGR for the US vitamin K2 market during the forecast period 2025 - 2035 is 4.46%. **Q: Which product type segment is projected to have the highest valuation by 2035?** A: The MK-4 & Combination Drugs segment is projected to reach $25.0 Billion by 2035. **Q: What are the two main sources of vitamin K2 in the market?** A: The two main sources of vitamin K2 in the market are Natural, projected at $16.8 Billion, and Synthetic, projected at $25.2 Billion by 2035. **Q: Which form of vitamin K2 is expected to grow significantly by 2035?** A: The Capsules & Tablets form is expected to grow to $16.5 Billion by 2035. **Q: What applications are driving the US vitamin K2 market?** A: The Nutraceutical and Food & Pharmaceutical applications are driving the US vitamin K2 market, with projections of $17.0 Billion and $25.0 Billion respectively by 2035. **Q: Who are the key players in the US vitamin K2 market?** A: Key players in the US vitamin K2 market include NattoPharma, Ginkgo BioWorks, Kappa Bioscience, DSM Nutritional Products, MenaQ7, FrieslandCampina, Nutraceutical Corporation, and Swanson Health Products. **Q: What was the valuation of the Natural source segment in 2024?** A: The valuation of the Natural source segment in 2024 was $10.4 Billion. **Q: How does the projected growth of the Synthetic source segment compare to the Natural source segment by 2035?** A: By 2035, the Synthetic source segment is projected to reach $25.2 Billion, significantly higher than the Natural source segment's projection of $16.8 Billion. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-vitamin-k2-market-13537*